Mantle Cell Lymphoma: Are New Therapies Changing the Standard of Care?
The prognosis of mantle cell lymphoma (MCL) has improved rapidly over recent years with the evolution of new management strategies. The disease, once considered fatal, has now become more of a chronic illness, with recurrent relapses that can be managed with a variety of treatment modalities, such a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2018-12-01
|
| Series: | European Medical Journal Oncology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/oncology/article/mantle-cell-lymphoma-are-new-therapies-changing-the-standard-of-care/ |